BioLyo Technologies

Technologiepark-Zwijnaarde 94

9052 Gent

BE

BioLyo Technologies

Foundation date

06/01/2020

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

BioLyo Technologies is dedicated to the development of live micro-organisms to be used as vaccines or biotherapeutics. The company is offering services to third parties to help speed up the development of their live biologicals by offering, GMP compatible and scaleable process development related to the development of media, fermentation strategies, harvest, pre-and post lyophilization formulation and lyophilization of live biological products. Moreover, for start-up Biotechs with development capability in house, BioLyo is also offering consultancy based on its long hands-on experience.   

Upcoming events

Latest news

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023

  • Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

    Wednesday November 29th 2023

  • Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure

    Wednesday November 29th 2023